RecruitingPhase 3

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

China716 participantsStarted 2021-07-01

Plain-language summary

This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.

Who can participate

Age range18 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age of women \<43 years at the time of stimulated IVF * Replacing early cleavage embryos or blastocysts after thawing Exclusion Criteria: * Requiring hormonal replacement cycles * Use of donor oocytes or embryos * Undergoing preimplantation genetic testing * Presence of hydrosalpinx not corrected surgically prior to FET * Refusal to join the study

What they're measuring

live birth rate

Timeframe: 10 months after recruitment

Trial details

NCT IDNCT03859921

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

Contact for this trial

Ernest HY Ng, MD

852-28553400 nghye@hku.hk

View on ClinicalTrials.gov More Subfertility trials